Arecor Therapeutics (LON:AREC) Trading Up 0.8%

Arecor Therapeutics plc (LON:ARECGet Rating) shares shot up 0.8% during trading on Thursday . The company traded as high as GBX 360 ($4.37) and last traded at GBX 352.65 ($4.28). 2,909 shares changed hands during mid-day trading, a decline of 27% from the average session volume of 3,961 shares. The stock had previously closed at GBX 350 ($4.25).

The company has a debt-to-equity ratio of 1.25, a quick ratio of 8.77 and a current ratio of 9.05. The stock has a market cap of ¬£102.99 million and a P/E ratio of -13.16. The stock’s fifty day simple moving average is GBX 382.76 and its 200-day simple moving average is GBX 379.17.

Arecor Therapeutics Company Profile (LON:AREC)

Arecor Therapeutics PLC, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products.

Recommended Stories

Want More Great Investing Ideas?

Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.